Basic Information
Basic information for SNHG14-267-35aa
Peptide Name SNHG14-267-35aa
Genome Position chr15:25247698-25247716,25249014-25249099[+]
Species Human
Peptide Sequence MALSGIDGEPGGRLVLGPYRPQASVCQPGAHPPVR
Peptide Length 35
Unique No (SNHG14-225-35aa,SNHG14-228-35aa,SNHG14-229-35aa,SNHG14-243-35aa,SNHG14-244-35aa,SNHG14-245-35aa,SNHG14-266-35aa-1,SNHG14-273-35aa,SNHG14-284-35aa,SNHG14-285-35aa,SNHG14-292-35aa,SNHG14-294-35aa,SNHG14-295-35aa,SNHG14-306-35aa,SNHG14-317-35aa-1,SNHG14-326-35aa,SNHG14-327-35aa-1,SNHG14-328-35aa-2,SNHG14-329-35aa,SNHG14-331-35aa)
Grand Average of Hydropathicity -0.2086
Relative Molecular Mass 4196.63
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000660430;SNHG14-267
Transcript Length 2541
Coding Ability 0.4553
DNA Sequence Corresponding to Peptide ATGGCCTTAAGCGGCATAGATGGTGAGCCTGGAGGAAGACTTGTATTGGGACCCTACAGGCCCCAGGCCAGTGTCTGTCAGCCTGGTGCTCATCCCCCAGTGCGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :